MedTrace Logo

Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

NCT00223561 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2006-03-01

No results posted yet for this study

Summary

The primary purpose of this study is to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patients.

Conditions

  • ADHD

Interventions

DRUG

methylphenidate

Sponsors & Collaborators

  • Utrecht Institute for Pharmaceutical Sciences

    lead OTHER

Principal Investigators

  • Joris Verster, PhD · Utrecht Institute for Pharmaceutical Sciences

  • Edmund Volkerts, PhD · Utrecht Institute for Pharmaceutical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Completion
2006-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00223561 on ClinicalTrials.gov